JeffreyCRobinsonMD

Pulmonology • Portland, OR

Critical Care Medicine, Pulmonary Vascular Medicine

Physician in Pulmonary and Critical Care

Join to view full profile

Dr. Robinson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Robinson's full profile

Already have an account?

Office
3181 SW Sam Jackson Park Rd
Portland, OR 97239
Phone+1 503-494-8311

Fax+1 503-346-6854
Is this information wrong?

Summary

Dr. Jeffrey Robinson is a pulmonary and critical care physician in Portland, OR and is associate professor at Oregon Health and Science University. He specializes in pulmonary vascular disease, including pulmonary hypertension and pulmonary embolism management and treatment. He also specializes in critical care medicine and cares for patients in the medical and cardiac intensive care units.

Education & Training

University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 2012 - 2016
University of California Davis HealthChief Residency, Internal Medicine, 2011 - 2012
University of California Davis HealthResidency, Internal Medicine, 2008 - 2011
Albert Einstein College of MedicineClass of 2008

Certifications & Licensure

OR State Medical License 2017 - 2025
CO State Medical License 2013 - 2019
CA State Medical License 2010 - 2012
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Clinical Trials

A Long-term Follow-up Study of Sotatercept for PAH Treatment (MK-7962-004/A011-12) Start of enrollment: 2021 May 12
Recruiting
Phase 3
A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR) Start of enrollment: 2021 Jan 25
Completed
Phase 3
GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2020 Nov 12
Completed
Phase 2
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients Start of enrollment: 2018 Aug 30
Recruiting
Phase 3
A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension Start of enrollment: 2020 Jul 07
Terminated
Phase 3
Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13) Start of enrollment: 2022 Mar 18
Recruiting
Phase 3
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension Start of enrollment: 2020 Jun 30
Recruiting
Phase 3
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) Start of enrollment: 2023 Dec 28
Recruiting
Phase 3
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) Start of enrollment: 2024 Jun 01
Not yet recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Premorbid weight in pulmonary arterial hypertension.
Laura J Oppegard, Lia M Barros, Hongyang Pi, James Kornfield, Catherine L Hough, Samuel G Rayner, Jeffrey C Robinson, Peter J Leary> ;Pulmonary Circulation. 2023 Oct 1
Echocardiographic characteristics of patients with antisynthetase syndrome.
Jaimie L Bryan, Ralph Matar, Abheek Raviprasad, Veronica Kuteyeva, Eduardo Milla, Omkar Begateri, Divya Patel, Diana G Manjarres, Saminder S Kalra, Jeffrey Robinson, A...> ;Pulmonary Circulation. 2022 Apr 1
7 citations
Obesity in pulmonary arterial hypertension the pulmonary hypertension association registry
Jeff Min, Rui Feng, David B. Badesch, Erika Berman-Rosenzweig, Charles D. Burger, Murali M. Chakinala, Teresa De Marco, Jeremy Feldman, Anna R. Hemnes, Evelyn M. Horn,...> ;Annals of the American Thoracic Society. 2021 Feb 1
4 citations
Residence at moderately high altitude and its relationship with WHO Group 1 pulmonary arterial hypertension symptom severity and clinical characteristics: the Pulmonar...
Shoaib Fakhri, Kelly Hannon, Kelly Moulden, Ryan A. Peterson, Peter Hountras, Todd M. Bull, James P. Maloney, Teresa De Marco, D. Dunbar Ivy, Thenappan Thenappan, J.S....> ;Pulmonary Circulation. 2020 Nov 10
9 citations
Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry.
Nicholas A. Kolaitis, Roham T. Zamanian, Vinicio A. de Jesus Perez, David B. Badesch, Raymond L. Benza, Charles D. Burger, Murali M. Chakinala, Jean M. Elwing, Jeremy ...> ;Annals of the American Thoracic Society. 2021 Apr 1
Age-related differences in hemodynamics and functional status in pulmonary arterial hypertension: Baseline results from the Pulmonary Hypertension Association Registry.
DesJardin JT, Kolaitis NA, Kime N, Kronmal RA, Benza RL, Elwing JM, Lammi MR, McConnell JW, Presberg KW, Sager JS, Shlobin OA, De Marco T, PHAR Investigators> ;The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2020-05-16
89 citations
TGF-β activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension.
Rajesh Kumar, Claudia Mickael, Biruk Kassa, Liya Gebreab, Jeffrey C. Robinson, Daniel E. Koyanagi, Linda Sanders, Lea Barthel, Christina Meadows, Daniel L. Fox, David ...> ;Nature Communications. 2017 May 30
Use and Abuse of the Medical Loss Ratio to Measure Health Plan Performance
Jeffrey Robinson, MD> ;Health affairs (Project Hope).
11 citations
Long-Term Health Outcomes in High-Altitude Pulmonary Hypertension.
Jeffrey C. Robinson, Cheryl Abbott, Christina A. Meadows, Robert C. Roach, Benjamin Honigman, Todd M. Bull> ;High Altitude Medicine & Biology. 2017 Mar 1
3 citations
Fatty Acid Metabolism, Bone Morphogenetic Protein Receptor Type 2, and the Right Ventricle
Brian B. Graham, Jeffrey C. Robinson, Rubin M. Tuder> ;American Journal of Respiratory and Critical Care Medicine. 2016 Sep 15
10 citations
Anticoagulation in Pulmonary Arterial Hypertension
Jeffrey C. Robinson, Steven C. Pugliese, Daniel L. Fox, David B. Badesch> ;Current Hypertension Reports. 2016 Apr 30
32 citations
The Crossroads of Iron with Hypoxia and Cellular Metabolism. Implications in the Pathobiology of Pulmonary Hypertension
Jeffrey C. Robinson, Brian B. Graham, Tracey C. Rouault, Rubin M. Tuder> ;American Journal of Respiratory Cell and Molecular Biology. 2014 Jul 2
Pathology of pulmonary hypertension.
Tuder RM, Stacher E, Robinson J, Kumar R, Graham BB> ;Clin Chest Med. 2013 Dec
3 citations
Fat and Cardiotoxicity in Hereditary Pulmonary Hypertension
Rubin M. Tuder, Jeffrey C. Robinson, Brian B. Graham> ;American Journal of Respiratory and Critical Care Medicine. 2014 Feb 1
6 citations
Updated approach for the assessment of ventilator-associated pneumonia
Madison Macht, Jeffrey C. Robinson, Brian B. Graham> ;Critical Care Medicine. 2013 Nov 1
18 citations
A splice site mutation in hERG leads to cryptic splicing in human long QT syndrome
Qiuming Gong, Li Zhang, Arthur J. Moss, G. Michael Vincent, Michael J. Ackerman, Jeffrey C. Robinson, M. Jones, David J. Tester, Zhengfeng Zhou> ;Journal of Molecular and Cellular Cardiology. 2008 Mar 1
44 citations
Defective assembly and trafficking of mutant HERG channels with C-terminal truncations in long QT syndrome
Qiuming Gong, David Keeney, Jeffrey C. Robinson, Zhengfeng Zhou> ;Journal of Molecular and Cellular Cardiology. 2004 Dec 1
Capital Finance and Ownership Conversions in Health Care
Jeffrey Robinson, MD> ;Health Affairs.
Vertical Integration and Organizational Networks in Health Care
Jeffrey Robinson, MD> ;Health Affairs.
Health Care Purchasing and Market Changes in California
Jeffrey Robinson, MD> ;Health Affairs.
Join now to see all

Journal Articles

TGF-Β Activation by Bone Marrow-Derived Thrombospondin-1 Causes Schistosoma- and Hypoxia-Induced Pulmonary Hypertension
William J Janssen, Jeffrey C Robinson, Rubin M Tuder, Kurt R Stenmark, Nature
Alpha-1 antitrypsin and the pathogenesis of emphysema
Robinson JC, Tuder RM, Hunt J, Minerva Pneumologica, 12/2013

Books/Book Chapters

Pulmonary Circulation: Diseases and Their Treatment
Chapter: Endothelin Receptor Antagonists
Robinson JC, Fox DL, Pugliese S, Dempsey JE, Graham BB, Bull T, Badesch DEditors: Rubin LJ.Taylor and Francis PublishersEdition 4th,2016
Pulmonary Hypertension: Basic Science to Clinical Medicine
Chapter: Defining characteristics of pulmonary hypertension
Robinson JC, Kumar R, Tuder RMEditors: Maron B.Springer GroupEdition 1st,2015

Abstracts/Posters

Long Term Health Outcomes of Individuals with High Altitude Pulmonary Hypertension: A 55-year Follow-up Study
Robinson JC, Abbott C, Roach RC, Honigman B, Bull TM, American Thoracic Society International Conference, San Francisco, CA, 5/2016
Exogenous Iron Supplementation in Acute Hypoxic Pulmonary Hypertension Leads to Decreased Hypoxia Inducible Factor Stabilization and Attenuated Right Ventricular Systo...
Robinson JC, Kumar R, Acosta D, Graham BB, Tuder RM, American Thoracic Society International Conference, Denver, CO, 5/2015
Iron Deficiency is Protective in Experimental Pulmonary Hypertension
Robinson JC, Kumar R, Graham BB, Tuder RM, American Thoracic Society International Conference., San Diego, CA, 5/2014
In a Female Mice Model of Pulmonary Hypertension (Hypoxia/Sugen), the Right Ventricle Adapts with Hypertrophy and Proliferation
Robinson JC, Wong A, Wood T, Li N, Lopez JE, Department of Internal Medicine Academic Forum, University of California, Davis
Hypoxia-induced pulmonary remodeling is associated with re-expression of beta-myosin heavy chain in right and left ventricular cardiac myocytes
Robinson JC, Haynam S, Wong A, Ander B, Chiamvimonvat N, Lopez JE., Department of Internal Medicine Academic Forum, University of California, Davis
Norepinephrine blocks cardiac myocyte regeneration by inducing a developmental program of cell cycle arrest
Robinson JC, Long CS, Simpson PC, Chiamvimonvat N, Lopez JE, Department of Internal Medicine Academic Forum, University of California, Davis
Join now to see all

Professional Memberships

American Thoracic Society - ATS
Member
American Heart Association - AHA
Member
Pulmonary Vascular Research Institute
Member

Hospital Affiliations

OHSU HospitalPortland, Oregon